Brixton Biosciences

Cambridge, MA · Founded 2019 · Privately Held (backing)

Developer of a biomedical neuromodulation therapy designed to sustain pain relief and support mobility. Brixton Biosciences is based in Cambridge, MA and was founded in 2019. It has raised $41 million.

Last price · $/share
—
Implied valuation
—
Total raised
$41.0M
Last round
—

Who backs Brixton Biosciences?

11 investors
InvestorType
National Institutes of HealthOther
SV Health InvestorsVenture capital
FemHealth VenturesVenture capital
Schooner CapitalGrowth equity
Sparta GroupFamily office
PV Capital ManagementFamily office
Angel Physicians Fund—
Catalyst Health Ventures—
Excelestar Ventures—
Hub Angels Investment Group—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Brixton Biosciences investors

11 investors are on record for Brixton Biosciences, including National Institutes of Health, SV Health Investors, FemHealth Ventures and Schooner Capital. By type, the record holds 2 venture capital firms, 2 family offices and 1 growth equity firm.

Free account
More of Brixton Biosciences with a free account
  • ·The complete investor list: 11 names
  • ·Watch Brixton Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Brixton Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View